Citizen in a RepublicNH Bill Briefing
← All bills

HB 117 · 2025 · House · Health, Human Services and Elderly Affairs Committee

Interchangeable biological drug substitution

AI-generated

relative to the substitution of biological products.

Modifies the definition of interchangeable biological product and allows pharmacists to substitute interchangeable biological products subject to certain restrictions.AI-generated

Status

Signed into law · July 22, 2025
  1. ✓Introduced
  2. ✓House
  3. ✓Senate
  4. ✓Governor
  5. ✓Law

Analysis

This bill modifies the definition of "interchangeable biological product" and allows for interchangeable biological products to be provided by pharmacists subject to certain restrictions.

From the bill's official ANALYSIS section.

In the bill's words

Quoted verbatim from the bill as enacted. Passages chosen from the operative text.Computed by this site

“"Biological product" means a virus, therapeutic serum, toxin, antitoxin, vaccine, blood, blood component or derivative, allergenic product, protein (except any chemically synthesized polypeptide), or analogous product, or arsphenamine or derivative of arsphenamine (or any other trivalent organic arsenic compound), applicable to the prevention, treatment, or cure of a disease or condition of human beings.”
RSA 318:47-dd
“(c) "Proper name" means the nonproprietary name for a biological product designated by the federal Food and Drug Administration license for use upon each package of the product.”
RSA 318:47-dd
“(d) "Interchangeable biological product" means a biological product that meets the definition under 42 U.S.C. section 262(i)(3) [the federal Food and Drug Administration:”
RSA 318:47-dd
“The board shall maintain a link on its website to the federal Food and Drug Administration's Lists of Licensed Biological Products with Reference Product Exclusivity and Biosimilarity or Interchangeability Evaluations.”
RSA 318:47-dd

Official record

Bill page — docket & status

gc.nh.gov · the authoritative source

Sponsors

Rep. Erica LayonRPrimeChair· Executive Departments and Administration
  • Rep. Anita BurroughsDRanking Member· Commerce and Consumer Affairs
  • Rep. Carry SpierDDeputy Ranking Member· Commerce and Consumer Affairs
  • Rep. John PotucekRVice Chair· Commerce and Consumer Affairs
  • Sen. Suzanne PrentissDAssistant Democratic Leader

Also: Rep. Jim KofaltR, Rep. Jonah WheelerD

Public testimony

111 signed in online · 27 wrote testimony

93% support7% oppose0% neutral

In their wordsVerbatim, exactly as submitted

“I support this bill. Brand name drugs are way too expensive due to the lack of competition in the market place . This bill will help bring competition to the drug industry allowing citizens to obtain needed medications at lower prices .”
— David Werner, Hollissupports
“Big Pharma has done enough to harm the public over decades of lobbying and lining the pockets of our politicians and physicians.…”
— Cynthia Taylor-Hollandbeck, Manchestersupports
“Big Pharma is not hurting for profits. They make money hand over fist while people are absolutely dependent (even addicted - SSRIs, etc.) to their medicines. The consumer should absolutely have the advantage of getting the lowest cost possible on these medications.…”
— Rebecca Nevin, Derrysupports
“Vaccines are biological products. I oppose legislation that would allow the substitution of antigen containing vaccines with mRNA shots without requiring clear informed consent to the consumer and for vaccines required for children to prevent swapping antigen containing vaccines for mRNA shots without specific legislative action to require mRNA shots.”
— Laura Condon, Bedfordopposes

Verbatim excerpts of submitted testimony, quoted from the testimony tool.

Read the testimony · as of Aug 12, 2026

Votes

yeanay
Starting text: Bill as introduced

Hearings and debates

  • Feb 19, 2025Public hearingHouse Health, Human Services and Elderly Affairs2:07:29–2:08:591m 30slocated in the stream transcriptPublic Hearing; Executive Session
  • Mar 20, 2025Floor debateHouse floorWatchnot located in the transcript — opens the full streamOught to Pass — adopted, voice vote
  • Apr 2, 2025Public hearingSenate Health and Human Services9:11–15:596m 48slocated in the stream transcriptHearing
  • Jun 5, 2025Floor debateSenate floorWatchnot located in the transcript — opens the full streamOught to Pass with Amendment #2025-2325s — adopted, voice vote; Committee Amendment # 2025-2325s — adopted, voice vote; Without Objection, the Clerk is authorized to make technical and administrative corrections which are necessary to reflect the intent of the Senate — adopted
  • Jun 12, 2025Floor debateHouse floor1:17:15–1:18:321m 17slocated in the stream transcriptHouse Concurs with Senate Amendment 2025-2325s (Rep. W. MacDonald) — adopted, voice vote
  • Jun 26, 2025Floor debateSenate floorWatchnot located in the transcript — opens the full streamEnrolled Adopted — voice vote

Timestamps locate where this bill is taken up in the chamber's YouTube stream.

Legislative history

  1. Jan 8, 2025HouseIntroduced 01/08/2025 and referred to Health, Human Services and Elderly Affairs HJ 2 P. 6
  2. Feb 19, 2025HousePublic Hearing: 02/19/2025 11:30 am LOB 202-204
  3. Feb 19, 2025HouseExecutive Session: 02/19/2025 11:30 am LOB 202-204
  4. Mar 5, 2025House: Ought to Pass 03/05/2025 (Vote 18-0; CC)
  5. Mar 20, 2025HouseOught to Pass: MA VV 03/20/2025 HJ 9 P. 17
  6. Mar 20, 2025SenIntroduced 03/20/2025 and Referred to Health and Human Services; SJ 9
  7. Apr 2, 2025SenHearing: 04/02/2025, Room 101, LOB, 09:45 am; SC 15
  8. Jun 5, 2025SenCommittee Amendment # 2025-2325s, AA, VV; 06/05/2025; SJ 15
  9. Jun 5, 2025SenOught to Pass with Amendment #2025-2325s, MA, VV; OT3rdg; 06/05/2025; SJ 15
  10. Jun 5, 2025SenWithout Objection, the Clerk is authorized to make technical and administrative corrections which are necessary to reflect the intent of the Senate, MA; 06/05/2025; SJ 15
  11. Jun 12, 2025HouseHouse Concurs with Senate Amendment 2025-2325s (Rep. W. MacDonald): MA VV 06/12/2025 HJ 17 P. 10
  12. Jun 26, 2025SenEnrolled Adopted, VV, (In recess 06/26/2025); SJ 18
  13. Jun 26, 2025HouseEnrolled (in recess of) 06/26/2025 HJ 18 P. 59
  14. Jul 15, 2025HouseSigned by Governor Ayotte 07/15/2025; Chapter 163; eff. 09/13/2025 HJ 18

Coverage

No reporting linked yet.

Documents (PDF)

Bill text & amendments link direct to gc.nh.gov; committee reports stream from the state record.